Wannan Medical College Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3

Organization Overview

First Clinical Trial
2012
NCT02965859
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

First Affiliated Hospital of Wannan Medical College | Wannan Medical College | Wannan Medical College Yijishan Hospital

Active Ingredients

Drugs in Phase 3 Trials (4)

gimeracil (1 trial)

oteracil (1 trial)

s-1 (1 trial)

tegafur (1 trial)

Drugs in Phase 2 Trials (2)

adefovir dipivoxil (hepsera) (1 trial)

metacavir (1 trial)

Drugs in Phase 1 Trials (1)

sy-004 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hepatitis (Phase 2)

Hepatitis A (Phase 2)

Hepatitis B (Phase 2)

Hepatitis B, Chronic (Phase 2)

Hepatitis, Chronic (Phase 2)

Stomach Neoplasms (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 7